E. Ohman J or Asset Management AB Has $3.86 Million Stock Holdings in Synopsys, Inc. $SNPS

E. Ohman J or Asset Management AB raised its position in Synopsys, Inc. (NASDAQ:SNPS) by 19.8% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 7,820 shares of the semiconductor company’s stock after acquiring an additional 1,290 shares during the period. E. Ohman J or Asset Management AB’s holdings in Synopsys were worth $3,858,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the business. Lionshead Wealth Management LLC lifted its position in shares of Synopsys by 1.9% in the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after purchasing an additional 17 shares in the last quarter. YANKCOM Partnership increased its stake in Synopsys by 3.3% in the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock valued at $275,000 after buying an additional 17 shares during the last quarter. Manchester Capital Management LLC lifted its position in Synopsys by 5.3% during the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after buying an additional 17 shares in the last quarter. Hemington Wealth Management boosted its stake in shares of Synopsys by 10.1% during the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock worth $100,000 after buying an additional 18 shares during the last quarter. Finally, Concord Asset Management LLC VA grew its holdings in shares of Synopsys by 0.8% in the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock valued at $1,220,000 after acquiring an additional 18 shares in the last quarter. 85.47% of the stock is owned by institutional investors.

Synopsys Price Performance

NASDAQ:SNPS opened at $477.14 on Friday. The company has a market cap of $91.29 billion, a P/E ratio of 59.72, a P/E/G ratio of 3.97 and a beta of 1.16. The firm’s fifty day moving average price is $437.58 and its two-hundred day moving average price is $503.60. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s quarterly revenue was up 37.8% compared to the same quarter last year. During the same quarter last year, the company posted $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Key Stores Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Insider Activity

In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.62% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts recently issued reports on SNPS shares. Morgan Stanley upped their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Citigroup began coverage on shares of Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 target price on the stock. Piper Sandler cut their price target on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research note on Thursday, December 11th. Finally, Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their price objective for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Eleven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $562.13.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.